Position in AMLX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,589,832
+$778,662 QoQ
Shares Held
144,200
+10.7% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 207 holders
Holding Since
Jun 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Swiss National Bank holds $505,151,346 across 28 Drug Manufacturers - Specialty & Generic names. AMLX ranks #21 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,121,700 | $139,643,196 | |
| 2 | ZTS |
Zoetis Inc.
|
1,186,032 | $85,228,259 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
111,255 | $60,281,296 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
268,900 | $45,320,406 | |
| 5 | VTRS |
Viatris Inc
|
2,336,402 | $37,102,063 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,001,992 | $24,659,023 | |
| 7 | ALKS |
Alkermes plc.
|
316,900 | $16,605,560 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
130,654 | $14,494,754 |
All Filings in AMLX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,589,832 | 144,200 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,811,170 | 130,300 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,953,336 | 161,700 | Shares | Sole | 2026-02-12 | |
| 2024-03-31 | $245,944 | 86,600 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,173,184 | 79,700 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,217,615 | 66,500 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,410,678 | 65,400 | Shares | Sole | 2023-08-09 | |
| No filing history on record for this holder in this stock. | ||||||